AIM(SZ:300446)2023-04-24 16:00Financial Performance - The company's revenue for Q1 2023 was ¥46,746,870.25, representing an increase of 11.00% compared to ¥42,115,035.28 in the same period last year[8]. - Net profit attributable to shareholders decreased by 12.99% to ¥1,378,568.40 from ¥1,584,388.42 year-on-year[8]. - The company reported a significant increase in other income, which rose by 1235.22% to ¥1,025,918.05 from ¥76,834.98 year-on-year[15]. - Net profit for the current period was ¥1,556,097.41, compared to ¥1,341,055.61 in the previous period, marking a 16.0% increase[43]. - The total comprehensive income for the current period was ¥1,556,097.41, compared to ¥1,341,055.61 in the previous period, indicating a growth of 16.0%[48]. - Basic and diluted earnings per share were both ¥0.0068, down from ¥0.0078 in the previous period[48]. Cash Flow - The net cash flow from operating activities was negative at -¥8,782,970.41, a decline of 161.15% compared to ¥14,362,343.01 in the previous year[8]. - The cash inflow from operating activities for the current period is CNY 44,778,822.38, compared to CNY 41,840,913.78 in the previous period, representing an increase of approximately 4.6%[24]. - The cash outflow from operating activities for the current period is CNY 53,561,792.79, compared to CNY 27,478,570.77 in the previous period, indicating a significant increase of approximately 94.8%[24]. - The net cash flow from investing activities was positive at ¥528,990.60, contrasting with a negative cash flow of ¥-15,861,942.79 in the previous period[44]. - The cash received from tax refunds in the current period is CNY 1,266,605.10, down from CNY 3,879,948.45 in the previous period, reflecting a decrease of approximately 67.3%[24]. - The company's total cash paid to employees in the current period is CNY 14,710,819.89, compared to CNY 11,150,992.61 in the previous period, marking an increase of approximately 32.3%[24]. - The cash and cash equivalents decreased from CNY 20,583,248.45 to CNY 11,732,033.97[32]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥811,270,082.05, down 0.52% from ¥815,496,152.30 at the end of the previous year[8]. - Total liabilities were reported at CNY 126,109,285.18, down from CNY 131,893,799.34[38]. - The company's total current assets amounted to CNY 338,630,783.15, a decrease from CNY 344,358,728.93[35]. - The company's equity attributable to shareholders amounted to CNY 654,388,189.28, slightly increasing from CNY 653,007,275.80[38]. - The company's total equity attributable to shareholders increased slightly by 0.21% to ¥654,388,189.28 from ¥653,007,275.80 at the end of the previous year[8]. Operational Metrics - The weighted average return on equity was 0.21%, a decrease of 0.03% from 0.24% in the same period last year[8]. - Total operating revenue for the current period reached ¥46,746,870.25, an increase of 11.6% compared to ¥42,115,035.28 in the previous period[39]. - Total operating costs increased to ¥46,971,928.32, up 17.5% from ¥39,986,045.19 in the previous period[39]. - Research and development expenses rose to ¥5,208,247.85, reflecting a 4.6% increase from ¥4,977,823.64 in the previous period[39]. - Accounts receivable increased from CNY 56,634,094.41 to CNY 65,887,518.80, indicating a growth of approximately 51.5%[32]. - Inventory rose from CNY 52,383,787.54 to CNY 57,947,553.50, reflecting an increase of about 10.7%[32]. - The company experienced a 197.41% increase in prepayments, reaching ¥13,414,490.98, attributed to expenses related to mergers and acquisitions[15]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 11,908, with the largest shareholder, China Lekai Group Co., Ltd., holding 30.61% of shares[20]. - The total number of shares held by the top ten unrestricted shareholders amounts to 70,000,000 shares, with China Lekai Group Co., Ltd. being the largest holder[21]. - The company has a total of 4,827,434 shares under lock-up restrictions at the end of the reporting period[27]. Strategic Initiatives - The company plans to issue shares to acquire 100% of the equity of Chuan Nan Aerospace Energy Technology Co., Ltd. and Chengdu Aerospace Molding Co., Ltd., as part of a major asset restructuring project[28]. - The company has received approval from the Shenzhen Stock Exchange to resume the review of its asset restructuring transaction on March 29, 2023[30]. - The company is in the process of updating relevant materials for the asset restructuring, which is subject to approval by the Shenzhen Stock Exchange and the China Securities Regulatory Commission[30]. - The company invested CNY 150 million in its subsidiary Cangzhou Lekai Chemical to enhance competitiveness and sustainable development[31]. - After the investment, the company will hold 90.7232% of Cangzhou Lekai Chemical's shares, which will become a controlled subsidiary[31]. Financial Challenges - Financial expenses surged by 61571.63% to ¥327,130.99 compared to ¥530.44 in the previous year, primarily due to decreased interest income and increased exchange losses[15]. - The net cash flow from operating activities was negative at ¥-8,782,970.41, a significant decrease from ¥14,362,343.01 in the previous period[44]. - The cash and cash equivalents at the end of the period decreased to ¥11,732,033.97 from ¥34,779,932.05 in the previous period[44].